Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Neurology
|
February 20, 2026
Reader Response: Alzheimer Disease Is a Specific Disorder Defined by Neuropathology Detectable During Life
Nicolas Villain
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Nicolas Villain
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|
August 5, 2022
Therapeutic news in Alzheimer’s disease: soon a disease-modifying therapy?
Nicolas Villain
La Revue Du Praticien
|
January 31, 2024
[How to deal with memory complaints]
Nicolas Villain
JAMA Neurology
|
September 13, 2021
US Food and Drug Administration Approval of Aducanumab-Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
Vincent Planche, Nicolas Villain
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 29, 2024
2024 AA criteria for Alzheimer's disease diagnosis: Mainly anchored at Aβ not tau
Alexis Moscoso, Nicolas Villain
JAMA Neurology
|
April 24, 2023
Advocating for Demonstration of Disease Modification-Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?
Vincent Planche, Nicolas Villain
Seminars in Neurology
|
March 30, 2019
Alzheimer's Disease Including Focal Presentations
Nicolas Villain, Bruno Dubois
Nature Reviews. Neurology
|
August 8, 2024
Disentangling clinical and biological trajectories of neurodegenerative diseases
Nicolas Villain, Vincent Planche
European Journal of Neurology
|
April 15, 2024
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries
Nicolas Villain, Robin Michalon
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Neurology
|
February 20, 2026
Reader Response: Alzheimer Disease Is a Specific Disorder Defined by Neuropathology Detectable During Life
Nicolas Villain
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Nicolas Villain
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|
August 5, 2022
Therapeutic news in Alzheimer’s disease: soon a disease-modifying therapy?
Nicolas Villain
La Revue Du Praticien
|
January 31, 2024
[How to deal with memory complaints]
Nicolas Villain
JAMA Neurology
|
September 13, 2021
US Food and Drug Administration Approval of Aducanumab-Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
Vincent Planche, Nicolas Villain
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 29, 2024
2024 AA criteria for Alzheimer's disease diagnosis: Mainly anchored at Aβ not tau
Alexis Moscoso, Nicolas Villain
JAMA Neurology
|
April 24, 2023
Advocating for Demonstration of Disease Modification-Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?
Vincent Planche, Nicolas Villain
Seminars in Neurology
|
March 30, 2019
Alzheimer's Disease Including Focal Presentations
Nicolas Villain, Bruno Dubois
Nature Reviews. Neurology
|
August 8, 2024
Disentangling clinical and biological trajectories of neurodegenerative diseases
Nicolas Villain, Vincent Planche
European Journal of Neurology
|
April 15, 2024
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries
Nicolas Villain, Robin Michalon
Page
of 8